- Home
- CPRX vs GENI Comparison
CPRX vs GENI Comparison
Compare CPRX & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- GENI
- Stock Information
- Founded
- CPRX 2002
- GENI 2016
- Country
- CPRX United States
- GENI United Kingdom
- Employees
- CPRX N/A
- GENI N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- GENI Services-Misc. Amusement & Recreation
- Sector
- CPRX Health Care
- GENI Consumer Discretionary
- Exchange
- CPRX Nasdaq
- GENI Nasdaq
- Market Cap
- CPRX 2.6B
- GENI 3.0B
- IPO Year
- CPRX 2006
- GENI N/A
- Fundamental
- Price
- CPRX $20.82
- GENI $11.48
- Analyst Decision
- CPRX Strong Buy
- GENI Strong Buy
- Analyst Count
- CPRX 5
- GENI 17
- Target Price
- CPRX $33.20
- GENI $13.88
- AVG Volume (30 Days)
- CPRX 1.6M
- GENI 5.0M
- Earning Date
- CPRX 11-05-2025
- GENI 11-11-2025
- Dividend Yield
- CPRX N/A
- GENI N/A
- EPS Growth
- CPRX 183.96
- GENI N/A
- EPS
- CPRX 1.65
- GENI N/A
- Revenue
- CPRX $558,499,000.00
- GENI $558,439,000.00
- Revenue This Year
- CPRX $16.51
- GENI $28.54
- Revenue Next Year
- CPRX $9.58
- GENI $17.14
- P/E Ratio
- CPRX $12.64
- GENI N/A
- Revenue Growth
- CPRX 28.55
- GENI 25.76
- 52 Week Low
- CPRX $19.05
- GENI $6.72
- 52 Week High
- CPRX $26.58
- GENI $13.73
- Technical
- Relative Strength Index (RSI)
- CPRX 58.08
- GENI 35.40
- Support Level
- CPRX $19.05
- GENI $11.76
- Resistance Level
- CPRX $21.07
- GENI $12.20
- Average True Range (ATR)
- CPRX 0.59
- GENI 0.53
- MACD
- CPRX 0.16
- GENI -0.17
- Stochastic Oscillator
- CPRX 60.27
- GENI 7.26
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.